Quaker Chemical (KWR) VP reports RSU vesting, dividend rights and share sale

Rhea-AI Filing Summary

Quaker Chemical Corp officer Andre Frodl, VP, R&D-Metals & Metalworking, reported equity transactions dated 12/15/2025 involving restricted stock units that converted into common stock. He acquired 172 shares of common stock upon vesting of restricted stock units and 6 shares from related dividend equivalent rights, each right being the economic equivalent of one share of KWR common stock.

On the same date, he disposed of 85 shares of common stock at $138.96 per share, and following these transactions he directly beneficially owned 611 shares of Quaker Chemical common stock. The underlying time-based restricted stock units were granted on 12/15/2022, vesting 50% on 06/15/2024 and 50% on 12/15/2025.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frodl Andre

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, R&D-Metals & Metalworking

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2025		M		172	A	(1)	690	D
Common Stock	12/15/2025		M		6	A	(2)	696	D
Common Stock	12/15/2025		F		85	D	$138.96	611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	12/15/2025		M			172	(3)	(3)	Common Stock	172	$0	0	D
Dividend Equivalent Rights	(2)	12/15/2025		M			6	(2)	12/15/2025	Common Stock	6	(2)	0	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis.

2. Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock.

3. On December 15, 2022, the reporting person was granted 344 time-based restricted stock units, vesting 50% on June 15, 2024 and 50% on December 15, 2025.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Andre Frodl	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What stock transactions did Quaker Chemical Corp (KWR) report for Andre Frodl on December 15, 2025?

The report shows that on 12/15/2025, Andre Frodl acquired 172 shares of Quaker Chemical common stock from vested restricted stock units and 6 shares from related dividend equivalent rights. On the same date he disposed of 85 shares of common stock at a price of $138.96 per share.

How many Quaker Chemical (KWR) shares does Andre Frodl own after these transactions?

After the reported transactions on 12/15/2025, Andre Frodl directly beneficially owned 611 shares of Quaker Chemical common stock.

What are the terms of the restricted stock units reported by Quaker Chemical (KWR)?

The filing explains that restricted stock units convert into common stock on a one-for-one basis. On 12/15/2022, Andre Frodl was granted 344 time-based restricted stock units that vest 50% on 06/15/2024 and 50% on 12/15/2025.

How do the dividend equivalent rights on KWR common stock work in this report?

The dividend equivalent rights reported for KWR settled in connection with the vesting of restricted stock units. These rights accrued when and as dividends were paid on KWR common stock, and each right was the economic equivalent of one share of KWR common stock.

What derivative securities did Quaker Chemical (KWR) report for Andre Frodl?

The filing lists restricted stock units and dividend equivalent rights as derivative securities. On 12/15/2025, 172 restricted stock units and 6 dividend equivalent rights were settled into an equal number of common shares, leaving zero derivative securities beneficially owned afterward.

What is Andre Frodls role at Quaker Chemical Corp (KWR) according to this filing?

According to the report, Andre Frodl is an officer of Quaker Chemical Corp, serving as VP, R&D-Metals & Metalworking, and the Form 4 is filed by one reporting person.